Clinical Evaluation of Siddha Medicine Sambirani Poo Kuligai for Soothaga Vaayu (PCOS)

Phase II non randomized open clinical evaluation of siddha medicine sambirani poo kuligai for the management of soothaga vaayu (PCOS) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/057015

Enrollment

Registered

2023-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Samibirani Poo Kuligai: 65 mg, bd after food with sugar(sarkkarai), for 7 days from day 5 of menstrual cycle Control Intervention1: Not Apllicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: Oligo and/or anovulation Hyperandrogenism (clinical and/or biochemical) Polycystic ovaries (Unilateral or bilateral)

Exclusion criteria

Exclusion criteria: Thyroid dysfunction Hyper prolactinemia Cushing syndrome Congenital adrenal hyperplasia Any serious systemic illness

Design outcomes

Primary

Measure	Time frame
Reduction in number in size of ovarian cyst. Regulation of menstrual cycle. Regulation of hormonal profile within 10 to 12 weeksTimepoint: Reduction in number in size of ovarian cyst. Regulation of menstrual cycle within 10 to 12 weeks	—

Secondary

Measure	Time frame
Correction of dyslipidemia & correction of BMITimepoint: Outcome may be expected in a period of 3 months	—

Countries

India

Contacts

Public ContactDr MENAKA R

Govt siddha medical college, chennai

rangasamymenaka75@gmail.com9444669660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026